Photo
October 24, 2019
Illumina said it will continue to answer questions about its proposed acquisition of Pacific Biosciences ahead of a U.K. regulator's financial decision.
Stories this photo appears in:
Illumina’s $1.2 Billion Acquisition of Pacific Biosciences Tentatively Rejected
A U.K. antitrust regulator has tentatively rejected Illumina’s $1.2 billion acquisition of Pacific Bioscience with a final decision slated for December.
